Daniel Lavanchy

13.5k citations
66 papers · 7.1k · 4 hit papers · h-index 27

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Hepatitis Viruses Studies and Epidemiology
    • Liver Disease and Transplantation
  • Epidemiology top 0.2%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment
    • Influenza Virus Research Studies

Papers in

    • Hepatitis B Virus Studies 31
    • Liver Disease Diagnosis and Treatment 22
    • Influenza Virus Research Studies 9
    • Respiratory viral infections research 4
    • Hepatitis C virus research 41
    • Hepatitis Viruses Studies and Epidemiology 9

Daniel Lavanchy

65 papers receiving 6.7k citations

Daniel Lavanchy's Hit Papers

Evolving epidemiology of hepatitis C virus 2010 · 1.0k citations
1.0k0+8+17Years since publication50010001.5k2.0k

Peers

Daniel Lavanchy
Comparison fields: 5 of 136
  • Hepatology 4.5k
  • Epidemiology 4.5k
  • Infectious Diseases 580
  • Virology 118
  • Immunology 354
Replace Colin W. Shepard with:
Colin W. Shepard United States
R. Palmer Beasley United States
Annemarie Wasley United States
Hui Zhuang China
Steven Wiersma United States
Myron J. Tong United States
Daniel Shouval Israel
Lu‐Yu Hwang United States
M J Alter United States
Sandra Ciesek Germany
Daniel Lavanchy relative to Colin W. Shepard United States Colin W. Shepard's profile →
Citations per field
00.5×1.5×2.1×
Colin W. Shepard · 1×
Citations per year

Countries citing papers authored by Daniel Lavanchy

Since Specialization
Citations

This map shows the geographic impact of Daniel Lavanchy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lavanchy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lavanchy more than expected).

Fields of papers citing papers by Daniel Lavanchy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lavanchy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lavanchy. The network helps show where Daniel Lavanchy may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Lavanchy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Lavanchy Line = papers co-authored together Daniel Lavanchy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
Hit paper breakdown →
20042108
2
The global burden of hepatitis C
Hit paper breakdown →
20091053
3
Evolving epidemiology of hepatitis C virus
Hit paper breakdown →
20101021
4
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Hit paper breakdown →
2000806
5 2005372
6
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.
1999349
7 2005118
8 200886
9 200276
10 201074
11 201270
12
Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group
200469
13 199568
14 200568
15 200853
16 201050
17 199949
18 199736
19 201535
20 199334

About Daniel Lavanchy

Daniel Lavanchy is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (31 papers), Liver Disease Diagnosis and Treatment (22 papers), Influenza Virus Research Studies (9 papers), Hepatitis Viruses Studies and Epidemiology (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Respiratory viral infections research (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). The work is most often cited by research in Hepatology (4.5k citations), Epidemiology (4.5k citations), Infectious Diseases (580 citations), Virology (118 citations) and Immunology (354 citations). Daniel Lavanchy has collaborated with scholars based in Switzerland, United States and Belgium. Frequent co-authors include Christina Frank, G. Thomas Strickland, Wagida A. Anwar, Mostafa K. Mohamed, Ray R. Arthur, Laurence S. Magder, Ismail Sallam, Mary Ellen Kitler, P. C. Frei and Pierre Van Damme. Their work appears in journals such as Vaccine, Journal of Hepatology, PLoS ONE, Journal of Viral Hepatitis and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact